Cases 51 - 60 of 221
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2015cv00902
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Limited , Aurobindo Pharma USA Inc. , Breckenridge Pharmaceutical Inc. and others
Counter_claimant:
Sigmapharm Laboratories LLC and Prinston Pharmaceutical Inc.
Counter_defendant:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Flamel Ireland, Ltd. v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00178
Plaintiff:
Flamel Ireland, Ltd.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 145
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al
as 1:2015cv07009
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP , ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Defendant:
MYLAN PHARMACEUTICALS INC. , MYLAN INC. and MYLAN LABORATORIES LIMITED
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00152
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences, Inc. and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_defendant:
Gilead Sciences Ireland UC , Gilead Sciences, Inc. , Janssen Pharmaceutica, N.V. and others
Cause Of Action: 35 U.S.C. § 271
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al
as 1:2015cv00149
Plaintiff:
GILEAD SCIENCES, INC. and EMORY UNIVERSITY
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_defendant:
EMORY UNIVERSITY and GILEAD SCIENCES, INC.
Cause Of Action: 28 U.S.C. § 1338
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00760
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences Ireland UC and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al
as 2:2015cv01455
Plaintiff:
Allergan, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd., Apotex, Inc. and others
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 3:2015cv05982
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
HEC PHARM GROUP , HEC PHARM CO., LTD. , HEC PHARM USA and others
Counter_claimant:
SUN PHARMACEUTICAL INDUSTRIES, INC. , SUN PHARMACEUTICAL INDUSTRIES LTD. , SUN PHARMA GLOBAL FZE and others
Counter_defendant:
BOEHRINGER INGELHEIM CORPORATION , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00130
Plaintiff:
Janssen Biotech, Inc. , Janssen Oncology, Inc. and Janssen Research & Development, LLC
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
